HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
April 27, 2022 at 03:36 pm
Share
HOB Biotech Group Corp.,Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 76.09 million compared to CNY 60.99 million a year ago. Revenue was CNY 76.09 million compared to CNY 60.99 million a year ago. Net income was CNY 13.56 million compared to CNY 13.34 million a year ago. Basic earnings per share from continuing operations was CNY 0.22 compared to CNY 0.23 a year ago. Diluted earnings per share from continuing operations was CNY 0.22 compared to CNY 0.23 a year ago.
HOB Biotech Group Corp Ltd is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic reagents. The Company provides two categories of products: allergy testing products and self-immune testing products. Its detection techniques include qualitative detection techniques such as enzyme-linked immunosorbent assay, and quantitative detection techniques such as enzyme-linked immunoassay capture method and nano-magnetic particle chemiluminescence method. The brands of allergy testing products include Oboke, Fubok, Shibok and Shibok Plus. The self-immune testing product brands include Norbok and Nabok. It is also engaged in the provision of reagent supporting testing instruments and others. The Company conducts its businesses in the domestic market.